CVS Health enhances its direct-to-consumer weight management offerings to improve access, affordability, care and support for GLP-1 medications

Go back to CVS Health enhances its direct-to-consumer weight management offerings to improve access, affordability, care and support for GLP-1 medications
CVS Caremark Corp. (NYSE: CVS) Delayed: 93.45 -1.3 (1.37%)
Previous Close $94.75    52 Week High $106.67 
Open $95.26    52 Week Low $69.30 
Day High $95.26    P/E 24.92 
Day Low $93.42    EPS $3.75 
Volume 6,526,737